Where is Design Therapeutics’ corporate headquarters?
Design Therapeutics is headquartered at
6005 Hidden Valley Road,
Suite 110 Carlsbad,
California, 92011
When was the company founded?
Design Therapeutics was founded and commenced operations in 2017.
When did Design Therapeutics go public?
Design Therapeutics’ initial public offering (IPO) occurred on March 26, 2021.
When is Design Therapeutics’ fiscal year-end?
Design Therapeutics’ fiscal year ends on December 31st.
How is Design Therapeutics’ stock traded?
Design Therapeutics is traded on the NASDAQ Global Market under the ticker symbol DSGN, and its CUSIP number is 0001807120.
Who is Design Therapeutics’ transfer agent?
Equiniti Trust Company, LLC
PO Box 500
Newark, NJ 07101
Inquiries may also be sent to helpAST@equiniti.com
Who are Design Therapeutics’ independent auditors?
Ernst & Young LLP
4365 Executive Dr # 1600
San Diego, CA 92121
Who is Design Therapeutics’ legal counsel?
Cooley LLP
10265 Science Center Dr
San Diego, California 92121
(858) 550-6000
Where can I get the latest corporate news releases and financial reports?
How can I view documents Design Therapeutics has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
Design Therapeutics’ SEC filings can be viewed at this
page
Whom should I contact if I have further questions?
You can submit queries to Design Therapeutics’ investor relations department by contacting investors@designtx.com.
